Today's edition is sponsored by Wati. Their support keeps these briefings free and focused on what actually matters.
The Senate bought the hemp industry a month and the House may take it back, with Andy Harris spending August making the case against his own chamber's leadership. FDA is six months past the deadline Congress set for defining the words that ban depends on, which by now says more about the agency than about the workload. California sent Gavin Newsom a bill that names unicorns and dragons in statute. And in New Mexico, three licensees went to court two days before the state turns off the system they are legally required to use.
🧭 The delay meets the House
🧾 FDA still owes the definitions
🔎 Tennessee's 99 percent
The law must be stable, but it must not stand still.
House Freedom Caucus Chairman Andy Harris has spent August arguing that the Senate's one-month hemp reprieve should not survive the House. He helped write the original ban into law alongside Mitch McConnell, he chairs the Agriculture appropriations subcommittee, and he has been conspicuous about not saying he will vote down the continuing resolution if the provision stays in. That last part is the tell. Twenty-one Senate Republicans, roughly 40 percent of the conference, voted against tabling Ted Budd's amendment to strip the delay, and that tally is the best available proxy for House Republican sentiment. Morgan Griffith, who wants the ban postponed and replaced with a real regulatory framework, told Roll Call that leadership's math turns on how many Democrats back the underlying bill.
My read is that the delay survives, and it survives through suspension rather than the Rules Committee. Rules invites an amendment that sends the bill back to the Senate during the week government funding expires, and nobody in leadership wants that. Suspension needs two-thirds, which means it needs Democrats, which means it does not need Harris. He gets to be loudly against it and the December 11th date holds anyway. I would revise that if Harris says out loud he will vote no, or if leadership schedules a rule, either of which would tell you they think they have the votes without the other side. Watch which calendar the bill lands on in the week of September 22nd. (Roll Call)
The statute that recriminalizes most hemp products on November 12th gave FDA 90 days to publish three lists of cannabinoids and to explain what "container" means. That deadline was February 10th. The Congressional Research Service flagged the miss in May and flagged it again last week, which is the institutional way of saying nothing has moved. Container is the unit the whole limit hangs on, since 0.4 milligrams of total THC per container means nothing until somebody defines the vessel. Jim Higdon of Cornbread Hemp told Marijuana Moment it is hard to comply with a law whose key definitions are still open, which is the mildest possible way to describe being asked to reformulate a product line against an undefined denominator.
Give the agency its due first. Ninety days is short for anything requiring a scientific determination per substance, the work crosses two centers and the field organization, and nothing publishes until it clears HHS general counsel and in practice OMB. The same staff handles infant formula and dietary supplements, and FDA has spent two years reorganizing its foods program while absorbing reductions. That is real. It is also true that FDA told Congress in 2023 it did not want this job under existing authorities and asked for a new pathway, and an institution that has already decided where a job belongs queues it accordingly when everything is overdue. Neither of those is a scandal, and both point the same direction.
So the lists do not appear before November 12th, and whatever eventually runs in the Federal Register will be narrower than industry hopes and later than Congress intended. The cost lands on operators deciding in October what to manufacture, and on the state regulators who get asked to enforce a federal limit measured in a unit nobody has defined. (Congressional Research Service; Marijuana Moment)
🚬 Gallup finds 17 percent of American adults smoke cannabis, double the 7 percent it measured when it first asked in 2013, while cigarette smoking has fallen to 11 percent. The same survey has the country split 47 to 46 on whether cannabis helps or hurts most users. The behavior won and the argument stayed open. Anybody planning around normalization should sit with that second number for a minute. (Gallup; Marijuana Moment)
Assemblymember Jacqui Irwin's AB 2249 cleared the Senate 38-0 and the Assembly 69-1 and now sits on Gov. Gavin Newsom's desk. It defines "attractive to children" as designed or likely to appeal to anyone under 21, then names the tells: cartoons, figures who appear underage, mythological creatures including unicorns and dragons, characters tied primarily to children's entertainment, images of candy and cereal, and lettering shaped like overinflated bubbles. Realistic fruit survives when it identifies an ingredient or a growing region.
A state legislature wrote unicorns and dragons into the Business and Professions Code, and the reason it had to is the interesting part. California already banned cartoon packaging. What it lacked was a standard that survived an argument, so enforcement kept collapsing into a debate over whether a stylized mango counts. Irwin asked the State Auditor to review how the Department of Cannabis Control was enforcing the old rule before she wrote the new one. Like all of us, they were figuring it out. The California Cannabis Industry Association opposes the bill on cost grounds, and that objection is fair even where it does not carry the day. Newsom signs this, because a 38-0 child-safety vote is not veto material, and the restrictions take effect January 1, 2028.
Then the argument moves, the way it always does. The first licensee with a mascot that is technically none of the listed things will take it to the department, and if the department says no, to a court, and the list will get longer from there. That is how a clean two-page definition turns into a ten-page one. (Marijuana Moment; AB 2249)
🚗 A Yale School of Medicine and Connecticut Office of the Chief Medical Examiner study of 1,168 driver fatalities between 2018 and 2024 found cannabinoid positivity rose from 32.8 percent before legalization to 37.9 percent after, short of statistical significance, alongside significant increases among killed motorcyclists and among pedestrians. Presence in a body is a different fact from operation while impaired, and toxicology cannot tell you which one it found. As more people use a legal product, more of them will screen positive after a crash whether or not anyone was high behind the wheel. Collect this data, all of it, for years. Then describe it accurately, because a headline that turns exposure into impairment will produce law that misses the drivers who actually are impaired. (American Journal of Forensic Medicine and Pathology)
Between July 1st and July 23rd, the Tennessee Alcoholic Beverage Commission inspected 1,315 retailers whose agriculture-department licenses lapsed on June 30th without a replacement ABC license, and issued 15 warning letters. Roughly 99 percent had already stopped selling. Earlier in the year the commission identified more than 650 unlicensed sellers, reinspected every location, and found more than 95 percent had either licensed up or left the business. For scale, ABC agents inspected 836 licensed alcohol premises in June and wrote 150 citations, an 82 percent compliance rate. The analysis comes from Vicente LLP, a firm that sells compliance counsel and has an obvious interest in the conclusion, though the figures come from the commission's own July meeting.
The case for the federal ban assumes this market cannot be controlled short of prohibition, and Tennessee just spent six months disproving that with a liquor agency and a license requirement. Operators holding numbers like these should be walking them into their congressional delegations this month rather than in October. Those offices hear emergency room data every week from people whose full-time job is delivering it, and enforcement data almost never, because the only people who have it are busy running businesses. (Vicente LLP; Tennessee Alcoholic Beverage Commission)
Oasis Cannabis Co., The Grow NM and the Cannabis Association of New Mexico filed August 21st in the Second Judicial District Court for a temporary restraining order, naming the Cannabis Control Division, the Regulation and Licensing Department, CCD Director Todd Stevens and Superintendent Clay Bailey. BioTrack stops accepting transfers at 5 p.m. today regardless. The complaint's strongest passage works the rulebook. Rule 16.8.7.9 NMAC bars a licensee without a functional track-and-trace account from operating at all, and 16.8.7.11(C) prohibits transport or receipt during any loss of access, while the division's August 14th bulletin instructs licensees to keep working on paper and reconcile afterward. Plaintiffs' counsel Jason Bowles is asking only that BioTrack stay up until the division shows NMS2S, whatever that is, is ready.
Courts do not like enjoining an agency's operational timeline forty-eight hours out, and the division will point to its bulletin as evidence it has addressed the harm. Filing was still the right move, and it is the ordinary one. A licensee who cannot get a satisfying answer from the agency goes to the legislature, the governor, or the courthouse, whichever is open, which is how every regulated industry ends up with a rule set nobody designed on purpose. What I would expect instead is the judge pressing the state for something in writing that says nobody gets cited for operating on paper during the outage, and the division agreeing, because that costs the state nothing and it is what the licensees actually need. Either way, reconcile before the switch. A restraining order argued this close to a cutover is a coin flip, and your inventory numbers are not. (Cannabis Business Times; Oasis Cannabis Co. v. New Mexico Cannabis Control Division)
💵 Ohio sold roughly $777 million in cannabis through August 21st, a 28 percent jump over the $605 million logged across the same stretch last year, with about $666 million of it adult-use. The state counts 227 dual-use dispensaries open and another 50 holding provisional licenses. Ohio's legislature spent this year arguing about potency caps and tax structure while the market under argument grew by better than a quarter, which is roughly the position every legislature ends up in when it legalizes first and legislates second. (Ohio Division of Cannabis Control; The Marijuana Herald)
Aurora has told shareholders to take no action while its special committee reviews Curaleaf's offer. CEO Miguel Martin used the same statement to go at Curaleaf's account of the German business. The reimbursement segment hit by Germany's July 30th prescription change accounts for under 10 percent of Aurora's German volume, he said, and international medical revenue grew 17 percent year over year. Aurora also rejects the claim that it stonewalled earlier approaches. The offer stays open at least 105 days from its August 18th launch.
Both boards are talking about Gprocess and disclosure while the actual disagreement is what Aurora's European business is worth. Curaleaf's case for $4 depends on Aurora's position there being weaker than Aurora says it is, which is why Martin answered with segment percentages instead of adjectives. A special committee with 105 days does not need to say no. It needs to run the clock, shop the company quietly, and see whether anyone else wants EU-GMP manufacturing capacity at a price with a number four in front of it. My guess is Curaleaf either raises or walks by the end of that window, and that the German telemedicine and reimbursement rules do more to set the final price than either board does. (StratCann; Aurora Cannabis)
Holler Cannabis Company cut the ribbon on a Lexington cultivation facility Friday, 20 months after winning a tier 1 license in Kentucky's October 2024 lottery. Twenty months of rent, construction draws, and payroll before a single legal sale. Gov. Andy Beshear, who attended, said the rollout has moved more slowly than he wanted while also calling the program a success, and both halves of that are true. Kentucky now has 39 medical cannabis businesses open, including 11 cultivators, five processors, two safety compliance facilities and 21 dispensaries, with five more cultivators expected. More than 24,000 Kentuckians hold cards, and state law requires every step from cultivation to sale to happen inside Kentucky, so a slow cultivation buildout is a supply ceiling on patients rather than a scheduling inconvenience.
Anyone who has stood at one of these openings knows how wide the gap runs between the day a license issues and the day product exists, and it is always wider than the ribbon-cutting suggests. The good news is that the first cohort absorbs most of that lag. The next five cultivators will move faster because the local officials, the lenders, and the inspectors have all now done this once. Holler's flowering plants have about a week to go, and Kentucky's program becomes real one harvest at a time. (WEKU)
ADVERTISEMENT
Your competitor just replied. You're still typing.
A lead comes in on Instagram. Another on Messenger. Three more on SMS.
Your team switches tabs, repeats answers, and loses context while hot leads wait hours for replies. At 2am, nobody responds at all.
That’s not a people problem. It’s a process problem.
Wati brings Instagram DM, Facebook Messenger, TikTok, WhatsApp, SMS, RCS, and web chat into one AI-powered inbox. Automations instantly respond, qualify leads, and route conversations to the right person, 24/7.
Your team stops firefighting. Your leads stop waiting. Your pipeline starts moving.

The countdown: enacted effective dates and the comment windows that matter, each linked to its primary source.
Every enacted date, with primary sources and analysis, lives in our cannabis and hemp deadline tracker. Reviewed daily.
SHARE THE BRIEFING
Policy, Decoded grows best when it's shared deliberately. Three referrals earns a sticker pack. Five earns How to Be Heard, our guide to making public comment that regulators actually read.
Policy, Decoded reaches operators, investors, counsel and regulators every weekday morning. Three founding sponsorships are open.


